Hims & Hers Health

Hims & Hers was placed in Visa's Acquirer Monitoring Program after the number of credit card complaints in its subscription business for weight-loss products exceeded allowable thresholds in July. Each complaint carries an $8 penalty fee, which, according to internal documents, could result in a bill of nearly $75,000 due in September. Visa is demanding that the complaint rate be reduced to under 1.5% of transactions for three consecutive months; Hims & Hers says the number of disputed charges is relatively small and that it has implemented measures to improve the checkout process. » More on de.investing.com

Chief legal officer Soleil Boughton reported a non‑discretionary sale of 21,500 Hims & Hers Health shares on August 14 to satisfy tax withholding tied to vested restricted stock units, raising about $605,000 at $28.15 per share. Boughton retains 339,075 directly held shares and additional vested and unvested awards. The company faces a recent FTC lawsuit (a $47.5 million legal contingency) even as revenue grew 38% last quarter and management raised full‑year guidance, while the stock is down about 40% over the past year. » More on finance.yahoo.com

Chief Operating Officer Michael Chi disposed of 47,702 Hims & Hers Health shares on August 14 in a non-discretionary sale to cover tax obligations from multiple RSU vestings. Post-transaction he directly holds 470,687 Class A shares and still has nearly 600,000 RSUs that vest quarterly through June 2029, creating a steady cadence of equity delivery and automatic withholding events. The stock has fallen about 40% over the past year, and the company is pursuing rapid international expansion after its Eucalyptus acquisition while remaining near-term unprofitable on a TTM basis. » More on finance.yahoo.com